Biological Data Visualization Market Report 2026

The biological data visualization market size has grown rapidly in recent years. It will grow from $0.81 billion in 2025 to $0.93 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to growth in biological data generation, expansion of genomic and proteomic research, rising use of imaging technologies, increasing adoption of computational biology tools, availability of advanced research datasets.

The biological data visualization market size is expected to see rapid growth in the next few years. It will grow to $1.54 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to increasing investments in precision medicine research, rising demand for advanced visualization in drug discovery, expansion of multi-omics analysis, growing integration of visualization with AI analytics, increasing collaboration across digital research platforms. Major trends in the forecast period include increasing adoption of interactive biological visualization tools, rising use of multi-dimensional data representation, growing integration of AI-assisted data interpretation, expansion of cloud-based visualization platforms, enhanced focus on user-friendly scientific interfaces.

The rising demand for personalized medicine is expected to drive the growth of the biological data visualization market. Personalized medicine tailors medical treatments and healthcare interventions to individual patients based on characteristics such as genetic makeup, lifestyle, and preferences. This demand is fueled by advancements in genomics, increasing patient empowerment, and the growing recognition of individualized treatment approaches. Biological data visualization supports personalized medicine by visually representing patient-specific genetic, molecular, and clinical data to inform tailored treatment strategies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022, including seven cancer drugs and three for other diseases and conditions. Therefore, the rising demand for personalized medicine is propelling the biological data visualization market.

Major companies in the biological data visualization market are developing advanced solutions such as AI-powered single-cell analysis systems to overcome limitations in existing tools and gain a competitive advantage. AI-powered single-cell analysis systems integrate artificial intelligence (AI) and machine learning (ML) with single-cell sequencing and analysis techniques. They provide high-resolution insights into cellular heterogeneity, gene expression, and cellular interactions within complex biological systems. For instance, in May 2023, Deepcell, a US-based biotechnology company, launched the REM-I Platform, an AI-powered single-cell analysis system offering scalable single-cell imaging, high-dimensional analysis, and cell sorting capabilities. The platform enables classification and sorting of cells based on morphological and phenotypic data without labeling, along with real-time, high-resolution visualization of cellular heterogeneity, accelerating discoveries in cell biology and morpholomics.

In April 2023, Excelra Knowledge Solutions Private Limited, an India-based global bioinformatics company, acquired BISC Global for an undisclosed amount. The acquisition strengthens Excelra’s international presence, expands its bioinformatics platform and services, enhances data-driven drug discovery capabilities, and provides comprehensive solutions to life sciences clients worldwide. BISC Global is a Belgium-based international bioinformatics services company specializing in biological data visualization.

Major companies operating in the biological data visualization market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Sartorius AG, Nikon Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Carl Zeiss Meditec AG, QIAGEN N.V., Bio-Techne Corporation, Leica Microsystems, Promega Corporation, 10x Genomic Inc., Luminex Corporation, Abcam plc, Oxford Nanopore Technologies Ltd., Cell Signaling Technology Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Fluidigm Corporation.

North America was the largest region in the biological data visualization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological data visualization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biological data visualization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the biological data visualization market by increasing costs of imported high-performance computing hardware, graphics processors, imaging equipment components, and data storage systems used in visualization workflows. Research institutions and pharmaceutical companies in North America and Europe are most affected due to reliance on advanced imported hardware, while Asia-Pacific faces higher costs for visualization system exports. These tariffs are raising research infrastructure expenses and slowing system upgrades. However, they are also encouraging adoption of cloud-based visualization software, regional computing infrastructure, and software-driven visualization solutions that reduce hardware dependency.

The biological data visualization market research report is one of a series of new reports that provides biological data visualization market statistics, including biological data visualization industry global market size, regional shares, competitors with a biological data visualization market share, detailed biological data visualization market segments, market trends and opportunities, and any further data you may need to thrive in the biological data visualization industry. This biological data visualization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biological data visualization involves creating graphical representations of complex biological data to aid in understanding, interpreting, and communicating biological phenomena and relationships. This interdisciplinary field merges biology, computer science, and graphic design principles to develop visual tools that assist researchers, clinicians, and educators in analyzing and comprehending large datasets generated from various biological studies.

The primary techniques of biological data visualization include microscopy, magnetic resonance imaging, sequencing, X-ray crystallography, and others. Microscopy utilizes microscopes to visualize objects too small to be seen with the naked eye. It encompasses platforms such as Windows, Mac operating systems, Linux, and others, applied in cell and organism imaging, structural biology and molecular modeling, genomic analysis, alignments, phylogeny, evolution, and systems biology. These techniques find application in academic research, pharmaceutical and biological centers, hospitals and clinics, and other domains.

The biological data visualization market consists of revenues earned by entities by providing services such as genetic data visualization, transcriptomic data visualization, metabolomic data visualization, evolutionary data visualization, and structural biology visualization. The market value includes the value of related goods sold by the service provider or included within the service offering. The biological data visualization market also includes sales of genome browsers, protein structure visualization software and heatmap generators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the developers or creators of these visualization tools, whether to other entities (including research institutions, biotechnology companies, healthcare providers, and educational organizations) or directly to end users. The value of goods in this market includes related services provided by the creators of these tools.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.